Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective, Multicenter, Multinational Study to Assess the Safety and Performance of the Easyx Antia Liquid Embolic in Intracranial Interventions IDEALE Study

NCT02863133 is registered in ClinicalTrials.gov with Antia Therapeutics AG as lead sponsor.

NCT NCT02863133
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02863133 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective, Multicenter, Multinational Study to Assess the Safety and Performance of the Easyx Antia Liquid Embolic in Intracranial Interventions IDEALE Study
Lead sponsor
Antia Therapeutics AG
Phase
Not applicable
Overall status
Unknown status
Start date
October 31, 2016
Completion date
October 31, 2018
Enrollment
65 (estimated)
Sites
Not reported

Conditions

As the registry lists them; a condition with its own page is linked.

arterial embolization